Method for treating glaucoma
A method for increasing outflow facility and reducing intraocular pressure from an eye of a subject having glaucoma includes the step of administering to the eye an amount of an ADP ribosyltransferase protein effective to reduce intraocular pressure and increase outflow facility.
1. A method for increasing outflow facility of aqueous humor from an eye having a trabecular meshwork, the method comprising the steps of:
providing to the trabecular meshwork an amount of an ADP ribosyltransferase protein effective to increase outflow facility.
2. A method as claimed in claim 1 wherein the providing step includes the step of delivering into trabecular meshwork cells a pharmaceutical composition that comprises a non-corneotoxic delivery vehicle and an expression vector that encodes the ADP ribosyltransferase such that ADP ribosyltransferase is produced in an amount effective to increase aqueous humor outflow facility from the trabecular meshwork.
3. A method as claimed in claim 2 wherein the expression vector is selected from the group consisting of an adenovirus vector, an adeno-associated virus vector, a herpes simplex virus-based vector, a lentivirus vector, and a plasmid vector.
4. A method as claimed in claim 2 wherein the expression vector is a lentivirus vector.
5. A method as claimed in claim 1 wherein the ADP ribosyltransferase is exoenzyme C3 transferase.
6. A method as claimed in claim 5 wherein the expression vector is a lentivirus vector.
7. A method as claimed in claim 1 wherein the providing step includes the step of administering a pharmaceutical preparation comprising a non-corneotoxic delivery vehicle and an ADP ribosyltransferase protein to the trabecular meshwork in an amount effective to increase aqueous humor outflow facility from the eye.
8. A method as claimed in claim 7 wherein the ADP ribosyltransferase is exoenzyme C3 transferase.